Learn more

FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO LTD

Overview
  • Total Patents
    194
  • GoodIP Patent Rank
    7,519
About

FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO LTD has a total of 194 patent applications. Its first patent ever was published in 2015. It filed its patents most often in China. Its main competitors in its focus markets organic fine chemistry and environmental technology are HANS VOIGT CHEM PHARM FABRIK D, JARI PHARMACEUTICAL CO LTD and ANHUI WANBEI PHARMACEUTICAL CO LTD.

Patent filings in countries

World map showing FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 194

Patent filings per year

Chart showing FOSHAN SAIWEISI PHARMACEUTICAL TECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cai Ziyang 190
#2 Deng Runqing 4

Latest patents

Publication Filing date Title
CN105153047A Tyrosine kinase inhibitor with novel benzoquinazoline and ortho-fluorine structure
CN105153046A Double-halogen-substituted ethoxy benz-quinazoline tyrosine kinase inhibitor and application thereof
CN105130913A Polysubstituted benzoquinazolines tyrosine kinase inhibitor and use thereof
CN104974084A 11beta-HSD1 (11-beta-hydroxysteroid dehydrogenase 1) inhibitor containing aminobipyridine tertiary alcohol structure and application thereof
CN104974080A 11beta-HSD1 (11-beta-hydroxysteroid dehydrogenase 1) inhibitor containing bipyridine tertiary alcohol structure as well as preparation method and application thereof
CN104961677A 11beta-HSD1 inhibitor of cyanobipyridine tert-alcohol structure and application of 11beta-HSD1 inhibitor
CN104961702A Benzisoxazole 11 beta-HSD1 inhibitor as well as preparation method and application thereof
CN104961703A Benzo-isoxazole 11beta-HSD1 inhibitor, preparation method and application
CN104974103A Compound containing benzisoxazole and alcoxylphenyl structure and application thereof
CN104910083A Alkoxylphenyl triazole sulfoxide 11beta-HSD1 inhibitor, preparation method and application thereof
CN104961698A Triazole sulfoxide compound with tail end substituted by nitro group, preparation method thereof and application thereof
CN104961696A Halobenzene triazole sulfoxide 11beta-HSD1 inhibitor, preparation method and application
CN104961697A Triazole sulfoxide compound with tail end substituted by halogen as well as a preparation method and an application thereof
CN104910084A Terminal amido replaced triazole sulfoxide, preparation method and application thereof
CN104892569A Terminal-substituted nitrobenzene hexamethylbenzene xanthate compound, preparation method and application
CN104892517A Hydrazine compound, method for preparing same and application of hydrazine compound
CN104910097A Halogenophenylthiazole carboxylic acid amide compounds containing phenylamidine structures as well as preparation method and application thereof
CN104892568A Xanthate ester compound containing haxamethyl benzene ring and nitrile group benzene structure and preparation method and application of xanthate ester compound
CN104892505A Glucokinase activator with halogenated quinoline and preparing method and application thereof
CN104910129A Xanthate compounds containing hexamethyl benzene ring and halogeno-benzene, and preparation method and application thereof